BLUE News Alert Bluebird Bio Inc (BLUE) 35.60 09/25/2014 20:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bluebird Bio Inc (BLUE) 35.60 $BLUE

Global Gene Therapy Market Outlook 2018
M2 - Wed Sep 17, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bqlkd5/global_gene) has announced the addition of the "Global Gene Therapy Market Outlook 2018" report to their offering. Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for difficult to cure' diseases. The gene therapy market, presenting a few marketable products and being nascent in terms of revenue generation, holds tremendous growth potential. As per a new estimation carried out in our latest study, the global gene therapy industry has the potential to become a multi-million dollar industry by the end of 2018, as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth. Primarily, the gene therapy market is dominated by oncology applications with several companies and academic institutions focusing on novel and difficult to treat' cancers. Other therapeutic areas seeing developments in gene therapy include cardiac conditions, inherited blindness, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report. Also, a brief overview of the key geographies in the gene therapy market and the regulatory scenario governing the industry has been included to present a balanced outlook. Unlike other regions globally, the United States continues to have the maximum number of clinical trials in the gene therapy segment. This shows the country's potential to become a leader in gene therapy in the coming years. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Gene Therapy - An Introduction Classification of Gene Therapy Techniques Physical Methods of Gene Transfer - Electroporation - Hydrodynamic - Microinjection - Particle Bombardment - Ultrasound-mediated Transfection Vectors for Gene Therapy - Adenoviral Vectors - Adeno-associated Virus Vectors - Retroviral Vectors - Lentiviral Vectors - Plasmid DNA 4. Industry Trends and Drivers Industry Trends - Gene Silencing: Gaining Momentum - Advanced Therapies: Combining Gene Therapy and Stem Cell Technology - Immunodeficiency Syndromes: The Focus of Gene Therapy - Nanotechnology: Empowering Gene Therapy - Gene Therapy: A New Hope to Treat Blindness - Gene Therapy: Potential Cure for Cancer Market Drivers - Failure of Conventional Therapies to Treat Cancers - Entry of Gene Therapies in Developed Nations - Rising Incidence of Chronic and Life Threatening Diseases - Growing Interest of Venture Capital Firms 5. Market Restraints - High Cost of Treatment - Stringent Regulatory Laws & Safety Concerns - Pitfalls in Current Technique 6. Gene Therapy Market Outlook - Oncology - Infectious Diseases - Genetic Disorders - Cardiovascular Disorders - Diabetes Mellitus - Neurological Disorders 7. Gene Therapy Market - Regulatory Landscape 8. Advanced Gene Therapy Drugs - Collategene - Allovectin-7 - Generx - Glybera 9. Mergers and Acquisitions - Sangamo BioSciences to Acquire Gene Therapy Company Ceregene. - Baxter to Acquire Chatham Therapeutics - Bluebird Bio Acquired Privately Held Gene-Editing Company - Miltenyi Acquired Gene Therapy Assets from Lentigen - Dutch Player UniQure to Acquire InoCard GmbH for CHF Therapy. 10. Key Players Analysis (Business Description, Clinical Pipeline, Recent Developments, Strengths & Weaknesses, Key People) - Spark Therapeutics, LLC - ViroMed Co. Ltd. dba VM BioPharma - Advantagene Inc - Bluebird Bio - Sanofi - Genzyme - A Sanofi Company - Kolon Life Science - Vical Inc - Oxford BioMedica - Genethon For more information visit http://www.researchandmarkets.com/research/bq...lobal_gene

Primp and Blow, a Blow Dry Bar, Aims Higher With New Location
PRWeb - Tue Sep 16, 6:21AM CDT
Primp and Blow, a blow dry bar, is set to open its fourth location on High Street (formally CityNorth) in Northeast Phoenix this week, joining restaurants and retail stores including Blue Martini, Modern Margarita and 42 Saint, The Offices on High Street, which will soon include Sprouts Farmers Market's new corporate headquarters and The Residences on High Street's luxury apartment rentals.

Insider Trading Alert - BLUE, BHI And HCP Traded By Insiders
at The Street - Thu Sep 04, 10:00AM CDT
Stocks with insider trader activity include BLUE, BHI and HCP

bluebird bio to Present at Morgan Stanley Global Health Care Conference
Business Wire - Tue Sep 02, 4:30PM CDT
bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2014 at 2.30 PM ( EDT) at the Grand Hyatt New York Hotel, New York, NY.

Bluebird Bio (BLUE) Stock: Weak On High Volume Today
at The Street - Tue Sep 02, 9:01AM CDT
Trade-Ideas LLC identified bluebird bio (BLUE) as a weak on high relative volume candidate

Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver
PR Newswire - Tue Sep 02, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BLUE, UTHR, MAT, ULTA and AMAT.

5 Stocks Triggering Big Breakout Trades
at The Street - Mon Aug 18, 10:12AM CDT
These stocks look poised to break out and trade higher from current levels.

bluebird bio Reports Fiscal Second Quarter 2014 Financial Results
Business Wire - Tue Aug 12, 4:00PM CDT
bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended June 30, 2014.

bluebird bio to Present at Two Upcoming Health Care Conferences
Business Wire - Tue Aug 05, 3:06PM CDT
bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Wedbush Life Science Conference on Wednesday, August 13, 2014 at 12.40 PM (EDT) at the Parker Meridian Hotel, New York, NY. Management will also present at the Canaccord Genuity Growth Conference on Thursday, August 14, 2014 at 2:00 PM (EDT) at the InterContinental Hotel, Boston, MA.

5 Stocks Ready for Breakouts
at The Street - Mon Aug 04, 9:14AM CDT
These stocks are within range of triggering breakout trades.

Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx
PR Newswire - Wed Jul 23, 7:30AM CDT
Today, Analysts Review released its research reports regarding Pfizer Inc. (NYSE: PFE), Gentiva Health Services Inc. (NASDAQ: GTIV), bluebird bio, Inc. (NASDAQ: BLUE), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5013-100free.

3 Biotech Stocks Breaking Out on Big Volume
at The Street - Mon Jul 21, 8:10AM CDT
These biotech stocks rising on unusual volume are within range of triggering breakout trades.

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 7:44AM CDT
bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 10% on the day.

Buying Bluebird's Blockbuster Potential at a Discount
at The Street - Thu Jul 17, 9:33AM CDT
It's not often an investor gets the opportunity to buy a biotech stock with two blockbuster indications in the pipeline and major catalysts only months away at such a discount.

bluebird bio Appoints Mark Vachon to its Board of Directors
Business Wire - Wed Jul 16, 3:05PM CDT
bluebird bio (Nasdaq: BLUE), a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy, today announced that Mark Vachon has joined the company's board of directors.

Grading Sobek's Mid-Year Biotech Stock Predictions
at The Street - Wed Jul 09, 9:14AM CDT
The year is halfway over, so it's a good time to look back and give mid-term grades on my fearless 2014 predictions.

bluebird bio Announces Pricing of Public Offering of Common Stock
Business Wire - Tue Jul 08, 5:58PM CDT
bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $34.00 per share, before underwriting discounts. In addition, bluebird bio has granted the underwriters a 30-day option to purchase from it up to an additional 450,000 shares of common stock.

Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The  Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...

Why bluebird bio Inc. Stock Faltered
Sean Williams, The Motley Fool - Motley Fool - Tue Jul 08, 1:17PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of bluebird bio , a clinical-stage...

bluebird bio Announces Proposed Public Offering of Common Stock
Business Wire - Mon Jul 07, 3:02PM CDT
bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that it has commenced an underwritten public offering of $100 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 105

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Neusoft's OneCoreGo Win Puts Auto Software in Focus

Updated Category News Views 65

A Dashboard Award Is Not Just About Pretty Pixels Crystal-like graphics and augmented-reality pathways may sound like the sort of thing a marketing department dreams up after too much coffee, but the more interesting bit in Neusoft's latest news is the machinery underneath. OneCoreGo 7.0 has received the Red Dot Design Award after taking a German iF Design Award earlier...

Continue Reading
IQSTEL’s 2027 Plan Has Scale but Still Needs Proof

Updated Category News Views 46

A $313 million nine-month revenue figure gets attention, yet this story is really about whether IQSTEL can finally turn a big telecom pipe into money that sticks. The company grew consolidated revenue 34.5% year over year through September 30, 2026, and third-quarter revenue hit $106.0 million, its second straight quarter above $100 million. That is real operating scale,...

Continue Reading
TSA at 25: Security Mission Meets a Tough Travel Reality

Updated Category News Views 104

Twenty-five years after its birth from catastrophe, TSA is still carrying a job nobody should take lightly. The agency marked its anniversary on November 19, 2026, looking back to the September 11, 2001 attacks that led to federalized aviation screening and a permanent reshaping of how Americans move through airports. This is not the sort of milestone that deserves...

Continue Reading
Winter Leaks Can Lock In Tarrant Sewer Costs for 2027

Updated Category News Views 44

Silent toilet seepage has a nasty habit of turning winter into a twelve-month utility hangover. Tarrant County homeowners are heading into the period when some local cities use household water consumption to calculate residential sewer charges for the following year. That is not the sort of detail anybody enjoys thinking about during the holidays, but ignoring it can be...

Continue Reading
Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 97

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 109

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 102

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 146

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
Pickleman’s Chips Turn a Side Into a Brand Signal Now

Updated Category News Views 79

A bag of dill pickle chips is hardly earthshaking news, yet this one says plenty about where fast-casual brands are trying to compete. Pickleman’s Gourmet Cafe is launching its own proprietary chip line with non-GMO ingredients, sunflower oil, a pared-down ingredient profile, and a flavor that actually fits the name on the door. More importantly, a portion of each...

Continue Reading

Top 5 Most Recently Viewed Articles

FRNT Financial Expands Its Investment Portfolio with BTC

Updated Category News Views 101

FRNT Financial's New Bitcoin Acquisition FRNT Financial Inc. has made headlines with the recent purchase of 3.14 BTC (Bitcoin), which totals an impressive C$500,000, roughly equivalent to US$115,594 per BTC. This acquisition highlights the company’s robust strategy to widen its investment horizons by venturing into digital assets, showcasing their keen understanding of...

Continue Reading
Pasinex Reports Q2 2025 Results with Key Developments Ahead

Updated Category News Views 143

Pasinex Resources Limited Financial Highlights Pasinex Resources Limited (CSE: PSE) has released its financial results for the second quarter ended June 30, 2025. The company’s latest earnings report highlights both challenges and strategic advancements as it aims for growth in the zinc market. Quarterly Performance Overview In Q2 2025, Pasinex reported a net loss of...

Continue Reading
Join the Class Action Against Perpetua Resources Corp. Today

Updated Category News Views 201

Understanding the Class Action Against Perpetua Resources Corp. In recent developments, a significant class action lawsuit has been initiated on behalf of investors in Perpetua Resources Corp. (NASDAQ: PPTA). This lawsuit arises from allegations that the company misrepresented critical information regarding the Stibnite Gold Project, leading to substantial financial...

Continue Reading
Celebrating Excellence: 2026 ACGME International Award Recipients

Updated Category News Views 304

Celebrating the 2026 ACGME International Awards In a significant announcement that highlights dedication to global medical education, ACGME International (ACGME-I) celebrates the recipients of the 2026 ACGME International Awards. These awards recognize exceptional individuals within institutions accredited by ACGME-I, shining a light on their commitment to enhancing...

Continue Reading
APTIM Achieves Top 10 Ranking in Environmental Management Again

Updated Category News Views 79

APTIM Maintains Stellar Position in Environmental Rankings In an impressive feat for the fourth consecutive year, APTIM has been celebrated in the Top 10 Environmental Management Firms according to a prestigious ranking by Engineering News-Record (ENR). This year, APTIM proudly holds the seventh position in environmental management and tenth in the nuclear waste category....

Continue Reading